Taja LesterManaging Partner at Health Equity Capital
Taja is Founder and Managing Partner of Health Equity Capital, a venture capital firm with a mission to help underserved patients benefit from cutting edge advances in science and technology. Taja founded Health Equity Capital and its affiliate, Health Equity Capital Impact, while serving on the Board of Directors at Women’s Cancer Research Center (WCRC), a non-profit organization which provides direct assistance to marginalized and low-income cancer patients; her experience overseeing health disparities related strategy and policy directly informed the mission of both organizations. Prior to founding Health Equity Capital (Impact), Taja spearheaded commercial planning efforts in women’s oncology for Avastin®, one of Roche Genentech’s largest brands. Before joining Genentech, Taja was a strategy consultant at PwC, where she advised c-level clients at leading healthcare and investment organizations. Before PwC, she took a lead role at Bay Bio (now California Life Science Association) where she sourced licensing opportunities for global pharmaceutical companies, across multiple markets and indications. Taja launched her venture capital career at Bay City Capital, a life science venture capital firm with over 1.5B AUM (USD). Taja was an early stage technology employee at CNET Networks (later acquired by CBS). Her tenure set the stage for a decade+ long career leading teams on the development and deployment of innovative digital health technologies at high-growth, emerging companies. Taja holds a BA from the University of California, Berkeley and an MBA from the Lorry I. Lokey School of Business (Mills College), where she cultivated expertise in women’s entrepreneurship, as a Goldman Sachs Scholar.